Guidant, Boston Scientific Take Heart In Merger Approval

Law360, New York (April 6, 2006, 12:00 AM EDT) -- After winning overwhelming approval from shareholders last week, Boston Scientific Corp. has won antitrust clearance from the Federal Trade Commission, pumping new blood into the long-awaited merger between the medical device maker and its rival Guidant.

Boston Scientific said that while the agreement is subject to final review and approval by the FTC, all outstanding antitrust issues related to the proposed Guidant transaction have been resolved.

The medical device maker also announced that pursuant to antitrust law, it will voluntarily withdraw and re-file its notification in...
To view the full article, register now.